Ind Swift Laboratories - API Business Unit

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Stage

Acquired Unit | Acquired

Valuation

$0000 

About Ind Swift Laboratories - API Business Unit

Ind Swift Laboratories (NSE: INDSWFTLAB) manufactures and exports active pharmaceutical ingredients (API) and advanced intermediates. The Indian pharma company serves the API requirements of regulated and soft regulated markets.On July 31st, 2021, Ind Swift Laboratories - API Business Unit was acquired by PI Industries at a valuation of $.21M.

Ind Swift Laboratories - API Business Unit Headquarter Location

Chandigarh,

India

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.